{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:46:49Z","timestamp":1790801209262,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00430-014-0359-9","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T18:53:53Z","timestamp":1412016833000},"page":"481-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines"],"prefix":"10.1007","volume":"204","author":[{"given":"Yun-Zhou","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"359_CR1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","volume":"12","author":"JB Ulmer","year":"2006","unstructured":"Ulmer JB, Wahren B, Liu MA (2006) Gene-based vaccines: recent technical and clinical advances. Trends Mol Med 12:216\u2013222","journal-title":"Trends Mol Med"},{"key":"359_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","volume":"239","author":"MA Liu","year":"2011","unstructured":"Liu MA (2011) DNA vaccines: an historical perspective and view to the future. Immunol Rev 239:62\u201384","journal-title":"Immunol Rev"},{"key":"359_CR3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","volume":"162","author":"L Li","year":"2012","unstructured":"Li L, Saade F, Petrovsky N (2012) The future of human DNA vaccines. J Biotechnol 162:171\u2013182","journal-title":"J Biotechnol"},{"key":"359_CR4","first-page":"109","volume":"71","author":"AD Bins","year":"2013","unstructured":"Bins AD, van den Berg JH, Oosterhuis K, Haanen JB (2013) Recent advances towards the clinical application of DNA vaccines. Neth J Med 71:109\u2013117","journal-title":"Neth J Med"},{"key":"359_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12026-008-8076-3","volume":"42","author":"SA Abdulhaqq","year":"2008","unstructured":"Abdulhaqq SA, Weiner DB (2008) DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 42:219\u2013232","journal-title":"Immunol Res"},{"key":"359_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","volume":"11","author":"F Saade","year":"2012","unstructured":"Saade F, Petrovsky N (2012) Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 11:189\u2013209","journal-title":"Expert Rev Vaccines"},{"key":"359_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000053992","volume":"43","author":"K Lundstrom","year":"2000","unstructured":"Lundstrom K (2000) Alphavirus vectors: applications for DNA vaccines production and gene expression. Intervirology 43:247\u2013257","journal-title":"Intervirology"},{"key":"359_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1466252312000011","volume":"13","author":"RL Vander Veen","year":"2012","unstructured":"Vander Veen RL, Harris DL, Kamrud KI (2012) Alphavirus replicon vaccines. Anim Health Res Rev 13:1\u20139","journal-title":"Anim Health Res Rev"},{"key":"359_CR9","first-page":"165","volume":"104","author":"HL Davis","year":"2000","unstructured":"Davis HL (2000) CpG motifs for optimization of DNA vaccines. Dev Biol (Basel) 104:165\u2013169","journal-title":"Dev Biol (Basel)"},{"key":"359_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1586\/14760584.2.2.305","volume":"2","author":"DM Klinman","year":"2003","unstructured":"Klinman DM (2003) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2:305\u2013315","journal-title":"Expert Rev Vaccines"},{"key":"359_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm813","volume":"9","author":"WW Leitner","year":"2003","unstructured":"Leitner WW, Hwang LN, deVeer MJ, Zhou A, Silverman RH, Williams BR, Dubensky TW, Ying H, Restifo NP (2003) Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9:33\u201339","journal-title":"Nat Med"},{"key":"359_CR12","doi-asserted-by":"crossref","first-page":"13412","DOI":"10.1128\/JVI.01799-07","volume":"81","author":"K Ljungberg","year":"2007","unstructured":"Ljungberg K, Whitmore AC, Fluet ME, Moran RS, Shabman ML, Collier AA, Kraus AA, Thompson JM, Montefiori DC, Beard C et al (2007) Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. J Virol 81:13412","journal-title":"J Virol"},{"key":"359_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1743-422X-8-36","volume":"8","author":"TI N\u00e4slund","year":"2011","unstructured":"N\u00e4slund TI, Kostic L, Nordstr\u00f6m EK, Chen M, Liljestr\u00f6m P (2011) Role of innate signaling pathways in the immunogenicity of alphaviral replicon-based vaccines. Virol J 8:36","journal-title":"Virol J"},{"key":"359_CR14","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1128\/JVI.06535-11","volume":"86","author":"ML Knudsen","year":"2012","unstructured":"Knudsen ML, Mbewe-Mvula A, Rosario M, Johansson DX, Kakoulidou M, Bridgeman A, Reyes-Sandoval A, Nicosia A, Ljungberg K, Hanke T et al (2012) Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine. J Virol 86:4082\u20134090","journal-title":"J Virol"},{"key":"359_CR15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.273.5273.352","volume":"273","author":"Y Sato","year":"1996","unstructured":"Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352\u2013354","journal-title":"Science"},{"key":"359_CR16","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","volume":"158","author":"DM Klinman","year":"1997","unstructured":"Klinman DM, Yamshchikov G, Ishigatsubo Y (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158:3635\u20133639","journal-title":"J Immunol"},{"key":"359_CR17","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.1073\/pnas.95.21.12631","volume":"95","author":"AM Krieg","year":"1998","unstructured":"Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, Yi AK, Short D, Davis HL (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 95:12631\u201312636","journal-title":"Proc Natl Acad Sci USA"},{"key":"359_CR18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1189\/jlb.1104627","volume":"78","author":"C Coban","year":"2005","unstructured":"Coban C, Ishii KJ, Gursel M, Klinman DM, Kumar N (2005) Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol 78:647\u2013655","journal-title":"J Leukoc Biol"},{"key":"359_CR19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/eji.201242690","volume":"43","author":"YZ Yu","year":"2013","unstructured":"Yu YZ, Li N, Ma Y, Wang S, Yu WY, Sun ZW (2013) Three types of human CpG motifs differentially modulate and augment immunogenicity of non-viral and viral replicon DNA vaccines as built-in adjuvants. Eur J Immunol 43:228\u2013239","journal-title":"Eur J Immunol"},{"key":"359_CR20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1189\/jlb.0106011","volume":"80","author":"V Hoene","year":"2006","unstructured":"Hoene V, Peiser M, Wanner R (2006) Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19. J Leukoc Biol 80:1328\u20131336","journal-title":"J Leukoc Biol"},{"key":"359_CR21","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1016\/j.vaccine.2011.05.047","volume":"29","author":"D Rynkiewicz","year":"2011","unstructured":"Rynkiewicz D, Rathkopf M, Sim I, Waytes AT, Hopkins RJ, Giri L, DeMuria D, Ransom J, Quinn J, Nabors GS, Nielsen CJ (2011) Marked enhancement of the immune response to BioThrax(R) (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers. Vaccine 29:6313\u20136320","journal-title":"Vaccine"},{"key":"359_CR22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1189\/jlb.1202630","volume":"73","author":"JD Marshall","year":"2003","unstructured":"Marshall JD, Fearon K, Abbate C, Subramanian S, Yee P, Gregorio J, Coffman RL (2003) Van Nest G (2003) Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J Leukoc Biol 73:781\u2013792","journal-title":"J Leukoc Biol"},{"key":"359_CR23","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1016\/j.vaccine.2007.10.016","volume":"25","author":"YZ Yu","year":"2007","unstructured":"Yu YZ, Zhang SM, Sun ZW, Wang S, Yu WY (2007) Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A. Vaccine 25:8843\u20138850","journal-title":"Vaccine"},{"key":"359_CR24","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.vaccine.2013.03.046","volume":"31","author":"YZ Yu","year":"2013","unstructured":"Yu YZ, Guo JP, An HJ, Zhang SM, Wang S, Yu WY, Sun ZW (2013) Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors. Vaccine 31:2427\u20132432","journal-title":"Vaccine"},{"key":"359_CR25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4161\/hv.22888","volume":"9","author":"Y Ma","year":"2013","unstructured":"Ma Y, Yu YZ, Zhu YF, Xu Q, Sun ZW (2013) In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli. Hum Vaccin Immunother 9:242\u2013249","journal-title":"Hum Vaccin Immunother"},{"key":"359_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","volume":"34","author":"J Vollmer","year":"2004","unstructured":"Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL et al (2004) Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 34:251\u2013262","journal-title":"Eur J Immunol"},{"key":"359_CR27","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1016\/j.vaccine.2011.05.087","volume":"29","author":"Y Liu","year":"2011","unstructured":"Liu Y, Luo X, Yang C, Yu S, Xu H (2011) Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice. Vaccine 29:5778\u20135784","journal-title":"Vaccine"},{"key":"359_CR28","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1128\/IAI.74.3.1699-1705.2006","volume":"74","author":"YS Chen","year":"2006","unstructured":"Chen YS, Hsiao YS, Lin HH, Liu Y, Chen YL (2006) CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB\/c mice. Infect Immun 74:1699\u20131705","journal-title":"Infect Immun"},{"key":"359_CR29","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/S0264-410X(02)00238-4","volume":"20","author":"Y Kojima","year":"2002","unstructured":"Kojima Y, Xin KQ, Ooki T, Hamajima K, Oikawa T, Shinoda K, Ozaki T, Hoshino Y, Jounai N, Nakazawa M et al (2002) Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 20:2857\u20132865","journal-title":"Vaccine"},{"key":"359_CR30","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1099\/0022-1317-83-12-2973","volume":"83","author":"RA Pontarollo","year":"2002","unstructured":"Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S (2002) Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 83:2973\u20132981","journal-title":"J Gen Virol"},{"key":"359_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.0022-202X.2004.23208.x","volume":"123","author":"A Schneeberger","year":"2004","unstructured":"Schneeberger A, Wagner C, Zemann A, Luhrs P, Kutil R, Goos M, Stingl G, Wagner SN (2004) CpG motifs are efficient adjuvants for DNA cancer vaccines. J Invest Dermatol 123:371\u2013379","journal-title":"J Invest Dermatol"},{"key":"359_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/dna.2005.24.292","volume":"24","author":"A Zhang","year":"2005","unstructured":"Zhang A, Jin H, Zhang F, Ma Z, Tu Y, Ren Z, Zhang X, Zhu K, Wang B (2005) Effects of multiple copies of CpG on DNA vaccination. DNA Cell Biol 24:292\u2013298","journal-title":"DNA Cell Biol"},{"key":"359_CR33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.fsi.2007.01.006","volume":"23","author":"Y Chen","year":"2007","unstructured":"Chen Y, Xiang LX, Shao JZ (2007) Construction of a recombinant plasmid containing multi-copy CpG motifs and its effects on the innate immune responses of aquatic animals. Fish Shellfish Immunol 23:589\u2013600","journal-title":"Fish Shellfish Immunol"},{"key":"359_CR34","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.vaccine.2010.11.073","volume":"29","author":"S Martinez-Alonso","year":"2011","unstructured":"Martinez-Alonso S, Martinez-Lopez A, Estepa A, Cuesta A, Tafalla C (2011) The introduction of multi-copy CpG motifs into an antiviral DNA vaccine strongly up-regulates its immunogenicity in fish. Vaccine 29:1289\u20131296","journal-title":"Vaccine"},{"key":"359_CR35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1189\/jlb.70.1.103","volume":"70","author":"LK Shoda","year":"2001","unstructured":"Shoda LK, Kegerreis KA, Suarez CE, Mwangi W, Knowles DP, Brown WC (2001) Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages. J Leukoc Biol 70:103\u2013112","journal-title":"J Leukoc Biol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0359-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-014-0359-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0359-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T21:54:56Z","timestamp":1689544496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-014-0359-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s00430-014-0359-9","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]}}}